Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

During the Trading Day
6.24 -0.05 / -0.79%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.24 0.00 / 0.00%
Volume: 9.4K
Health Technology

Company Description

Northwest Biotherapeutics, Inc. is a development stage company which is engaged in the development and discovery of innovative immunotherapy products to treat cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Contact Information

Northwest Biotherapeutics, Inc.
4800 Montgomery Lane
Bethesda Maryland 20814
P:(240) 497-9024
Investor Relations:
(202) 841-7909



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Linda F. PowersChairman, President, CEO, CFO & CAO
Alton L. BoyntonChief Scientific Officer, Secretary & Director
Marnix L. BoschChief Technology Officer
Anthony E. MaidaSenior Vice President-Clinical Research
Leslie J. GoldmanSVP-Business Development & Head-Investor Relations